Drugs of Abuse (DOA) Testing Global Market Report 2023

Drugs of Abuse (DOA) Testing Global Market Report 2023 – By Product And Service (Analyzers, Rapid Testing Devices, Consumables, Laboratory Services), By Sample Type (Urine, Hair, Oral Fluid, Breath), By Application (Pain Management, Criminal Justice, Workplace Screening), By End User (Hospitals, Diagnostic Laboratories, Forensic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 175 | Published : April 2023 | Delivery Time: 2-3 business days | Format :

Need assistance or more information before the purchase?

Enquire Before Buying
Infoimg

Proud Members Of

Drug of abuse (DOA) testing refers to the examination of a substance, such as a drug, chemical, or plant product, that is usually treated recreationally. It includes marijuana, cocaine, opioids, amphetamines, alcohol, and PCP, which are tested for on a drug panel. The patient's urine, saliva, blood, hair, or sweat are used in this clinical screening procedure.

The main products and services for drug of abuse (DOA) testing are analyzers, rapid testing devices, consumables, and laboratory services. An analyzer is a device that automatically measures the chemical concentration of one or more components or another associated physical quantity, continuously or intermittently. There are sample types included such as urine, hair, oral fluid, and breath, and are available in various applications such as pain management, criminal justice, and workplace screening. The end users involve hospitals, diagnostic laboratories, forensic laboratories, and others.

The global drugs of abuse (DOA) testing market is segmented -

1) By Product And Service: Analyzers, Rapid Testing Devices, Consumables, Laboratory Services

2) By Sample Type: Urine, Hair, Oral Fluid, Breath

3) By Application: Pain Management, Criminal Justice, Workplace Screening

4) By End User: Hospitals, Diagnostic Laboratories, Forensic Laboratories, Other End Users

The global drugs of abuse (DOA) testing market size is expected to grow from $6.03 billion in 2022 to $6.65 billion in 2023 at a compound annual growth rate (CAGR) of 10.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The global drug of abuse (DOA) testing market size is expected to reach $9.35 billion in 2027 at a CAGR of 8.9%.

Increasing demand for drug abuse treatment is expected to propel the growth of the drugs of abuse (DOA) testing market going forward. Drug abuse or substance abuse refers to the use of a substance in quantities that are harmful to the user or others. Drug testing aids in the identification of compounds that are not normally found in the body. The process starts with a screening test, which is followed by a second test to find and/or confirm the presence of a substance or substances, so increasing demand for drug abuse treatment will propel the market's growth. For instance, in June 2021, according to United Nations Office on Drugs and Crime (UNODC), a US-based drug control and crime prevention organization, combining the United Nations International Report 2021 World Drug Report, over 36 million individuals in the world have drug use disorders, and over 275 million people used drugs in 2020. Therefore, increasing demand for drug abuse treatment is driving the drug of abuse (DOA) testing market.

Major players in the drugs of abuse (doa) testing market are Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Dragerwerk AG & Co. KGaA, Quest Diagnostics Inc., United States Drug Testing Laboratories Inc., Thermo Fisher Scientific Inc., Siemens Healthcare Private Limited, F. Hoffmann-La Roche Ltd, Cordant Health Solutions, Omega Laboratories Inc., Psychemedics Corporation, Zimmer Biomet, Homology Medicines Inc., and bioMérieux Inc.

Technology advancement is a key trend gaining popularity in the drugs of abuse (DOA) testing market. Major companies operating in the drugs of abuse (DOA) testing market are focused on developing new technological solutions to strengthen their position in the market. For instance, in May 2020, a Canada-based technology company created instruments to detect THC in breath for law enforcement. Cannabix Technologies' point-of-care breath testing solutions is used for the detection of 9-tetrahydrocannabinol ("THC"), the psychoactive element in marijuana that contributes to impairment, are at the forefront of industry research and development. The THCBA detects THC in breath using microfluidic sensor technology. The THCBA includes appealing features such as single-stage direct breath capabilities and a one-handed ergonomic design. So far, testing has shown that the device can produce results in less than 5 minutes from the time the sample is eaten.

In June 2020, Medix Biochemica, a Finland-based biotechnology company, acquired Biostride Inc. for an undisclosed amount. With this acquisition, Biostride's array of drug of abuse antibodies and antigens is now available to IVD and drug testing customers worldwide. The acquisition is consistent with Medix's plan to streamline the IVD supply chain and emerge as the industry's top provider of vital raw materials. Biostride Inc. is a US-based producer of antibodies and antigens for the IVD industry for drugs of abuse and hormone testing.

North America was the largest region in the drugs of abuse (DOA) testing market in 2022. Asia-Pacific is expected to be the fastest-growing region in the global drugs of abuse (DOA) testing market report during the forecast period. The regions covered in the global drugs of abuse (DOA) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the drugs of abuse (DOA) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The drugs of abuse (DOA) testing market includes revenues earned by entities by providing services such as analyzers, rapid testing devices, consumables, and laboratory services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The drugs of abuse (DOA) testing market research report is one of a series of new reports from. The Business Research Company that provides drugs of abuse (DOA) testing market statistics, including drugs of abuse (DOA) testing industry global market size, regional shares, competitors with a drugs of abuse (DOA) testing market share, detailed drugs of abuse (DOA) testing market segments, market trends and opportunities, and any further data you may need to thrive in the drugs of abuse (DOA) testing industry. This drug of abuse (DOA) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Executive Summary

    2. Drugs of Abuse (DOA) Testing Market Characteristics

    3. Drugs of Abuse (DOA) Testing Market Trends And Strategies

    4. Drugs of Abuse (DOA) Testing Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Drugs of Abuse (DOA) Testing Market

    4.2. Ukraine-Russia War Impact On Drugs of Abuse (DOA) Testing Market

    4.3. Impact Of High Inflation On Drugs of Abuse (DOA) Testing Market

    5. Drugs of Abuse (DOA) Testing Market Size And Growth

    5.1. Global Drugs of Abuse (DOA) Testing Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Drugs of Abuse (DOA) Testing Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Drugs of Abuse (DOA) Testing Market Segmentation

    6.1. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Analyzers

    Rapid Testing Devices

    Consumables

    Laboratory Services

    6.2. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Urine

    Hair

    Oral Fluid

    Breath

    6.3. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Pain Management

    Criminal Justice

    Workplace Screening

    6.4. Global Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospitals

    Diagnostic Laboratories

    Forensic Laboratories

    Other End Users

    7. Drugs of Abuse (DOA) Testing Market Regional And Country Analysis

    7.1. Global Drugs of Abuse (DOA) Testing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Drugs of Abuse (DOA) Testing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Drugs of Abuse (DOA) Testing Market

    8.1. Asia-Pacific Drugs of Abuse (DOA) Testing Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Drugs of Abuse (DOA) Testing Market

    9.1. China Drugs of Abuse (DOA) Testing Market Overview

    9.2. China Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Drugs of Abuse (DOA) Testing Market

    10.1. India Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Drugs of Abuse (DOA) Testing Market

    11.1. Japan Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Drugs of Abuse (DOA) Testing Market

    12.1. Australia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Drugs of Abuse (DOA) Testing Market

    13.1. Indonesia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Drugs of Abuse (DOA) Testing Market

    14.1. South Korea Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Drugs of Abuse (DOA) Testing Market

    15.1. Western Europe Drugs of Abuse (DOA) Testing Market Overview

    15.2. Western Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Drugs of Abuse (DOA) Testing Market

    16.1. UK Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Drugs of Abuse (DOA) Testing Market

    17.1. Germany Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Drugs of Abuse (DOA) Testing Market

    18.4. France Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Drugs of Abuse (DOA) Testing Market

    19.1. Eastern Europe Drugs of Abuse (DOA) Testing Market Overview

    19.2. Eastern Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Drugs of Abuse (DOA) Testing Market

    20.1. Russia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Drugs of Abuse (DOA) Testing Market

    21.1. North America Drugs of Abuse (DOA) Testing Market Overview

    21.2. North America Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Drugs of Abuse (DOA) Testing Market

    22.1. USA Drugs of Abuse (DOA) Testing Market Overview

    22.2. USA Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Drugs of Abuse (DOA) Testing Market

    23.1. South America Drugs of Abuse (DOA) Testing Market Overview

    23.2. South America Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Drugs of Abuse (DOA) Testing Market

    24.1. Brazil Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Drugs of Abuse (DOA) Testing Market

    25.1. Middle East Drugs of Abuse (DOA) Testing Market Overview

    25.2. Middle East Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Drugs of Abuse (DOA) Testing Market

    26.1. Africa Drugs of Abuse (DOA) Testing Market Overview

    26.2. Africa Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Drugs of Abuse (DOA) Testing Market Competitive Landscape And Company Profiles

    27.1. Drugs of Abuse (DOA) Testing Market Competitive Landscape

    27.2. Drugs of Abuse (DOA) Testing Market Company Profiles

    27.2.1. Abbott Laboratories

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Danaher Corporation

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Laboratory Corporation of America Holdings

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Dragerwerk AG & Co. KGaA

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Quest Diagnostics Inc.

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Drugs of Abuse (DOA) Testing Market

    29. Drugs of Abuse (DOA) Testing Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Drugs of Abuse (DOA) Testing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Global Drugs of Abuse (DOA) Testing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: Asia-Pacific, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: China, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: India, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Japan, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Australia, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: Indonesia, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: South Korea, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: Western Europe, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: UK, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: Germany, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: France, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Eastern Europe, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: Russia, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: North America, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: USA, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: South America, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Brazil, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Middle East, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Africa, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 47: Abbott Laboratories Financial Performance
  • Table 48: Danaher Corporation Financial Performance
  • Table 49: Laboratory Corporation of America Holdings Financial Performance
  • Table 50: Dragerwerk AG & Co. KGaA Financial Performance
  • Table 51: Quest Diagnostics Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Drugs of Abuse (DOA) Testing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Global Drugs of Abuse (DOA) Testing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: Asia-Pacific, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: China, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: India, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Japan, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Australia, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: Indonesia, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: South Korea, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: Western Europe, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: UK, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: Germany, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: France, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Eastern Europe, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: Russia, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: North America, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: USA, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: South America, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Brazil, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Middle East, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Africa, Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 47: Abbott Laboratories Financial Performance
  • Figure 48: Danaher Corporation Financial Performance
  • Figure 49: Laboratory Corporation of America Holdings Financial Performance
  • Figure 50: Dragerwerk AG & Co. KGaA Financial Performance
  • Figure 51: Quest Diagnostics Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report